• 文献检索
  • 文档翻译
  • 深度研究
  • 学术资讯
  • Suppr Zotero 插件Zotero 插件
  • 邀请有礼
  • 套餐&价格
  • 历史记录
应用&插件
Suppr Zotero 插件Zotero 插件浏览器插件Mac 客户端Windows 客户端微信小程序
定价
高级版会员购买积分包购买API积分包
服务
文献检索文档翻译深度研究API 文档MCP 服务
关于我们
关于 Suppr公司介绍联系我们用户协议隐私条款
关注我们

Suppr 超能文献

核心技术专利：CN118964589B侵权必究
粤ICP备2023148730 号-1Suppr @ 2026

文献检索

告别复杂PubMed语法，用中文像聊天一样搜索，搜遍4000万医学文献。AI智能推荐，让科研检索更轻松。

立即免费搜索

文件翻译

保留排版，准确专业，支持PDF/Word/PPT等文件格式，支持 12+语言互译。

免费翻译文档

深度研究

AI帮你快速写综述，25分钟生成高质量综述，智能提取关键信息，辅助科研写作。

立即免费体验

铍肺病中特定隔室的蛋白质相互作用。

Compartment-specific protein interactions in beryllium lung disease.

作者信息

Li Li, Vestal Brian, Mroz Margaret M, Liu Sucai, MacPhail Kristyn, Griffin Tim J, Yang Ivana V, Maier Lisa A, Bhargava Maneesh

机构信息

Division of Environmental and Occupational Health Sciences, Department of Medicine, National Jewish Health, Denver, CO, USA.

Division of Pulmonary and Critical Care Sciences, Department of Medicine, School of Medicine, University of Colorado Anschutz Medical Campus, Aurora, CO, USA.

出版信息

ERJ Open Res. 2023 Nov 13;9(6). doi: 10.1183/23120541.00138-2023. eCollection 2023 Nov.

DOI:10.1183/23120541.00138-2023
PMID:37965231
原文链接:https://pmc.ncbi.nlm.nih.gov/articles/PMC10641575/
Abstract

https://bit.ly/3PLNTXC.

摘要

https://bit.ly/3PLNTXC. （链接无法翻译，保留原文）

https://cdn.ncbi.nlm.nih.gov/pmc/blobs/e5ef/10641575/ff77e7c0c646/00138-2023.01.jpg
https://cdn.ncbi.nlm.nih.gov/pmc/blobs/e5ef/10641575/ff77e7c0c646/00138-2023.01.jpg
https://cdn.ncbi.nlm.nih.gov/pmc/blobs/e5ef/10641575/ff77e7c0c646/00138-2023.01.jpg

相似文献

1
Compartment-specific protein interactions in beryllium lung disease.铍肺病中特定隔室的蛋白质相互作用。
ERJ Open Res. 2023 Nov 13;9(6). doi: 10.1183/23120541.00138-2023. eCollection 2023 Nov.
2
Beryllium increases the CD14(dim)CD16+ subset in the lung of chronic beryllium disease.铍会增加慢性铍病患者肺部CD14（dim）CD16 +亚群。
PLoS One. 2015 Feb 17;10(2):e0117276. doi: 10.1371/journal.pone.0117276. eCollection 2015.
3
An official American Thoracic Society statement: diagnosis and management of beryllium sensitivity and chronic beryllium disease.美国胸科学会官方声明：铍敏与慢性铍病的诊断与管理。
Am J Respir Crit Care Med. 2014 Nov 15;190(10):e34-59. doi: 10.1164/rccm.201409-1722ST.
4
HLA-DPB1 E69 genotype and exposure in beryllium sensitisation and disease.HLA-DPB1 E69 基因型与铍致敏和疾病的暴露有关。
Occup Environ Med. 2022 Feb;79(2):120-126. doi: 10.1136/oemed-2021-107736. Epub 2021 Sep 17.
5
SELDI-TOF derived serum biomarkers failed to differentiate between patients with beryllium sensitisation and patients with chronic beryllium disease.SELDI-TOF 衍生血清生物标志物未能区分铍致敏患者和慢性铍病患者。
Occup Environ Med. 2011 Oct;68(10):759-64. doi: 10.1136/oem.2010.058966. Epub 2011 Jan 27.
6
Influence of MHC class II in susceptibility to beryllium sensitization and chronic beryllium disease.主要组织相容性复合体II类分子在铍致敏和慢性铍病易感性中的作用
J Immunol. 2003 Dec 15;171(12):6910-8. doi: 10.4049/jimmunol.171.12.6910.
7
Mortality Among Individuals Diagnosed With Chronic Beryllium Disease and Beryllium Sensitization.慢性铍病和铍敏化个体的死亡率。
J Occup Environ Med. 2024 Mar 1;66(3):247-251. doi: 10.1097/JOM.0000000000003033. Epub 2023 Dec 19.
8
Polymorphism of FCGR3A gene in chronic beryllium disease.慢性铍病中 FCGR3A 基因的多态性。
Genes Immun. 2019 Jul;20(6):493-499. doi: 10.1038/s41435-018-0046-8. Epub 2018 Sep 24.
9
Risk of chronic beryllium disease by HLA-DPB1 E69 genotype and beryllium exposure in nuclear workers.核工作人员中 HLA-DPB1 E69 基因型和铍暴露导致慢性铍病的风险。
Am J Respir Crit Care Med. 2011 Jun 15;183(12):1680-8. doi: 10.1164/rccm.201002-0254OC. Epub 2011 Mar 11.
10
Frequency of beryllium-specific, TH1-type cytokine-expressing CD4+ T cells in patients with beryllium-induced disease.铍中毒性疾病患者中表达铍特异性、TH1型细胞因子的CD4 + T细胞的频率。
J Allergy Clin Immunol. 2005 May;115(5):1036-42. doi: 10.1016/j.jaci.2005.01.019.

本文引用的文献

1
The deacetylase SIRT2 contributes to autoimmune disease pathogenesis by modulating IL-17A and IL-2 transcription.去乙酰化酶 SIRT2 通过调节 IL-17A 和 IL-2 的转录促进自身免疫性疾病的发病机制。
Cell Mol Immunol. 2022 Jun;19(6):738-750. doi: 10.1038/s41423-022-00874-1. Epub 2022 May 6.
2
Sirtuin Control of Mitochondrial Dysfunction, Oxidative Stress, and Inflammation in Chagas Disease Models.Sirtuin 对恰加斯病模型中线粒体功能障碍、氧化应激和炎症的调控。
Front Cell Infect Microbiol. 2021 Jun 9;11:693051. doi: 10.3389/fcimb.2021.693051. eCollection 2021.
3
Dysregulation of SIRT-1 Signaling in Multiple Sclerosis and Neuroimmune Disorders: A Systematic Review of SIRTUIN Activators as Potential Immunomodulators and their Influences on other Dysfunctions.
SIRT-1 信号失调在多发性硬化症和神经免疫紊乱中的作用：SIRTUIN 激活剂作为潜在免疫调节剂及其对其他功能障碍影响的系统评价。
Endocr Metab Immune Disord Drug Targets. 2021;21(10):1845-1868. doi: 10.2174/1871530321666210309112234.
4
Phagosome-regulated mTOR signalling during sarcoidosis granuloma biogenesis.吞噬体调节的肌醇三磷酸信号通路在肉样瘤肉芽肿发生中的作用。
Eur Respir J. 2021 Mar 18;57(3). doi: 10.1183/13993003.02695-2020. Print 2021 Mar.
5
Novel protein pathways in development and progression of pulmonary sarcoidosis.肺结节病发生发展中的新蛋白通路。
Sci Rep. 2020 Aug 6;10(1):13282. doi: 10.1038/s41598-020-69281-8.
6
Host sirtuin 2 as an immunotherapeutic target against tuberculosis.宿主 SIRT2 作为抗结核免疫治疗靶点。
Elife. 2020 Jul 22;9:e55415. doi: 10.7554/eLife.55415.
7
Implication of the deacetylase sirtuin-1 on synovial angiogenesis and persistence of experimental arthritis.去乙酰化酶 SIRT1 对滑膜血管生成和实验性关节炎持续存在的影响。
Ann Rheum Dis. 2020 Jul;79(7):891-900. doi: 10.1136/annrheumdis-2020-217377. Epub 2020 May 7.
8
SIRT1 inhibits rheumatoid arthritis fibroblast-like synoviocyte aggressiveness and inflammatory response via suppressing NF-κB pathway.SIRT1 通过抑制 NF-κB 通路抑制类风湿关节炎成纤维样滑膜细胞的侵袭性和炎症反应。
Biosci Rep. 2018 Jun 21;38(3). doi: 10.1042/BSR20180541. Print 2018 Jun 29.
9
Preventing muscle wasting by osteoporosis drug alendronate in vitro and in myopathy models via sirtuin-3 down-regulation.通过下调 SIRT3，骨质疏松症药物阿仑膦酸钠在体外和肌肉疾病模型中预防肌肉减少症。
J Cachexia Sarcopenia Muscle. 2018 Jun;9(3):585-602. doi: 10.1002/jcsm.12289. Epub 2018 Mar 6.
10
Accurate proteome-wide label-free quantification by delayed normalization and maximal peptide ratio extraction, termed MaxLFQ.通过延迟归一化和最大肽段比率提取进行全蛋白质组精确的无标记定量，称为MaxLFQ。
Mol Cell Proteomics. 2014 Sep;13(9):2513-26. doi: 10.1074/mcp.M113.031591. Epub 2014 Jun 17.